Dry Powder Inhalable Vaccines For Shelf Stability And Global Access

This webinar tackles the challenge of limited access to vaccines due to complex storage requirements. Traditional vaccines need cold chain distribution (refrigeration or freezing), hindering global vaccination efforts.

The solution? Shelf-stable vaccines. Imagine an inhaled vaccine delivered via a dry powder formulation – no needles or cold storage needed. This webinar explores the science behind formulation with dry powder respiratory delivery:

• Global Need: We'll discuss the importance of shelf-stable vaccines for fighting pandemics, neglected tropical diseases, and achieving equitable access.
• Formulation Approach: Dive into the unique formulation required for a safe and effective dry powder vaccine for inhalation.
• Manufacturing Considerations: Learn about the spray drying process, a critical step in creating a stable and inhalable vaccine powder.
• Case Study: We explore a recent real-world example of collaboration developing a dry powder tuberculosis vaccine using spray drying technology.

Key Takeaways:

• Understand the global need for shelf-stable vaccines.
• Learn how dry powder vaccines are formulated and delivered.
• Gain insights into the spray drying process for inhaled vaccines.